Duane C, Glavey S, Quinn J, Murphy P. Significant risk of venous thromboembolism associated with targeted anti-myeloma immunomodulatory drugs. Comment on: Targeted anti-cancer agents and risk of venous thromboembolism. haematol [Internet]. 2020Sep.10 [cited 2025Mar.10];. Available from: https://haematologica.org/article/view/11971